NIAID DEA OA Acquisitions

The National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) Acquisitions Office, a civilian sub-agency within the Department of Health and Human Services, procures research, development, and support services for infectious-disease and immunology research and program delivery. NIAID awards contracts to academic institutions, private research organizations, and commercial vendors across the United States and internationally.

NIAID's contract activity spans 11,075 awards since 1993, with the most recent recorded award dated March 31, 2016. The portfolio carries a combined potential value of $22.81 billion, with $5.5 billion obligated to date. Award cadence over the final five years of recorded activity was 1,351 awards in 2012, 1,438 in 2013, 1,605 in 2014, 1,626 in 2015, and 304 in 2016 year-to-date through March. The substantial drop in 2016 reflects the truncation of activity records at the first quarter of that year; the full-year volume is not captured in the portfolio.

NIAID has awarded contracts to 1,777 distinct prime contractors across the portfolio history. The top contractors by award count and potential value are not reported in the source data; accordingly, competitive concentration cannot be assessed from the available figures.

The contract set-aside mix is highly skewed toward unrestricted procurement: 10,706 awards (97 percent) carried no set-aside designation. Small-business set-asides account for 310 awards (3 percent) of the total, including 26 Competitive 8(a) awards, 18 8(a) Sole Source awards, and scattered EDWOSB, WOSB, partial small-business, and SDVOSB designations. This distribution reflects NIAID's research-procurement model, in which most contracts flow to established academic medical centers and research institutions that do not qualify for small-business designations.

No recent contract opportunities are recorded in the source data. The portfolio activity cutoff date of March 31, 2016, is substantially prior to the evaluation date of October 22, 2026. Current and open solicitations cannot be determined from the available information.